Three Pathways to Convert CO₂ into Methane: Which Technology Is Commercially Viable Today?
April 30, 2026
Annie Nguyen
Source: David Strittmatter
CEO & Co-Founder ICODOS | ex-McK | Delivering RFNBO e-methanol production at scale. Mannheim, Baden-Württemberg, Germany
Converting CO₂ into methane is emerging as a key decarbonization pathway, with the Sabatier reaction forming the foundation of multiple technological approaches.
Core chemical reaction
CO2+4H2→CH4+2H2OCO_2 + 4H_2 rightarrow CH_4 + 2H_2OCO2+4H2→CH4+2H2O
While thermodynamically favorable, the reaction faces kinetic challenges due to the strong C=O bond in CO₂. Three main catalytic pathways are currently being pursued.
Thermocatalysis – the leading solution
Thermocatalysis uses nickel or ruthenium catalysts at 250–400°C and 1–30 bar.
It achieves:
- Over 95% CO₂ conversion
- Near 100% methane selectivity
- Around 80% efficiency with heat recovery
This is the most mature and commercially viable technology, already demonstrated at industrial scale.
Biocatalysis – the biological route
Biocatalysis relies on microorganisms to convert CO₂ and hydrogen at lower temperatures (40–70°C).
Advantages include:
- High methane purity (>98%)
- Ability to process raw biogas
- Tolerance to impurities like H₂S
However, scalability is limited by lower volumetric productivity.
Plasma catalysis – the emerging frontier
Plasma catalysis uses non-thermal plasma to activate CO₂ at bulk temperatures below 200°C.
Key features:
- Rapid response to intermittent renewable energy
- Enhanced conversion when combined with catalysts
Limitations:
- Energy efficiency remains at 30–55%
- No large-scale industrial deployment yet
The real constraint: hydrogen cost
All three pathways require four hydrogen molecules per methane molecule, making hydrogen cost the dominant factor.
This means:
- Methane production economics depend on hydrogen pricing
- Renewable electricity and electrolysis are decisive
Conclusion
Thermocatalysis currently stands as the most bankable solution. However, biocatalysis and plasma catalysis may gain ground as technologies mature.
Ultimately, the competition is less about reaction pathways and more about access to low-cost renewable hydrogen.





